Skip to Content

Clinical Trial Details

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Br Ca. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy

Objective

This randomized phase III trial studies how well giving hormone therapy together with or without everolimus work in treating patients with breast cancer. Read More >>

IRB Protocol Number
SWOG S1207

Clinical Trial Categories

  • Breast Cancer
Contact
Barbara Beauchemin, RN, BSN at 603-224-2556